Isabell Seibert

408 total citations
26 papers, 302 citations indexed

About

Isabell Seibert is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Isabell Seibert has authored 26 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Pediatrics, Perinatology and Child Health and 9 papers in Pharmacology. Recurrent topics in Isabell Seibert's work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Isabell Seibert is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Pharmacological Effects and Toxicity Studies (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). Isabell Seibert collaborates with scholars based in Switzerland, Germany and South Africa. Isabell Seibert's co-authors include Thomas Klimkait, Henriette E. Meyer zu Schwabedissen, Andrea Lubbe, Frank van der Kooy, Vinesh Maharaj, Heino Heyman, J.J.M. Meyer, François Sénéjoux, Markus Grube and Olivier Potterat and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Isabell Seibert

21 papers receiving 292 citations

Peers

Isabell Seibert

ONCOL

PHARM

PPCH

Claudia Finamore Italy

Sadhana Sharma India

Mathias Maitrejean France

Airong Yu China

S.C. Kim South Korea

Saroj Verma India

Riham Salah El-Dine Egypt

Mohammad Kaleem Ahmad India

Pattaraporn Vanachayangkul United States

Naoki Imaizumi Japan

Claudia Finamore Italy

Isabell Seibert

203 ×2.4

ONCOL

49 ×0.6

PHARM

125 ×1.7

43 ×0.6

20 ×0.5

PPCH

Citations per year, relative to Isabell Seibert Isabell Seibert (= 1×) peers Claudia Finamore

Countries citing papers authored by Isabell Seibert

Since Specialization

Citations

This map shows the geographic impact of Isabell Seibert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabell Seibert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabell Seibert more than expected).

Fields of papers citing papers by Isabell Seibert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabell Seibert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabell Seibert. The network helps show where Isabell Seibert may publish in the future.

Co-authorship network of co-authors of Isabell Seibert

This figure shows the co-authorship network connecting the top 25 collaborators of Isabell Seibert. A scholar is included among the top collaborators of Isabell Seibert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabell Seibert. Isabell Seibert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Seibert, Isabell, et al.. (2025). Erlotinib—A substrate and inhibitor of OATP2B1: pharmacokinetics and CYP3A-mediated metabolism in rSlco2b1−/− and SLCO2B1+/+ rats. Drug Metabolism and Disposition. 53(5). 100069–100069.

Brecht, Karin, et al.. (2025). Exploring the main source of coproporphyrins: Observations on transport in red blood cells. Drug Metabolism and Disposition. 53(7). 100108–100108.

Oswald, Stefan, et al.. (2025). Pregnenolone Sulfate Permeation at the Blood–Brain Barrier is Independent of OATP2B1—In Vivo and In Vitro Insights. Biopharmaceutics & Drug Disposition. 46(1). 33–46.

Brecht, Karin, et al.. (2024). Humanization of SLCO2B1 in Rats Increases rCYP3A1 Protein Expression but Not the Metabolism of Erlotinib to OSI-420. Journal of Pharmacology and Experimental Therapeutics. 389(1). 87–95. 3 indexed citations

Seibert, Isabell, et al.. (2024). Impact of OATP2B1 on Pharmacokinetics of Atorvastatin Investigated in rSlco2b1-Knockout and SLCO2B1-Knockin Rats. Drug Metabolism and Disposition. 52(9). 957–965. 4 indexed citations

Grube, Markus, et al.. (2024). Increased coproporphyrin serum levels in healthy volunteers treated with the cholesterol uptake inhibitor ezetimibe. Clinical and Translational Science. 17(10). e70041–e70041. 3 indexed citations

Grube, Markus, et al.. (2023). Various effects of repeated rifampin dosing on coproporphyrin levels in humans. Clinical and Translational Science. 16(11). 2289–2298. 6 indexed citations

Seibert, Isabell, et al.. (2023). St. John’s Wort Formulations Induce Rat CYP3A23-3A1 Independent of Their Hyperforin Content. Molecular Pharmacology. 105(1). 14–22. 2 indexed citations

Seibert, Isabell, et al.. (2023). Simultaneous quantification of atorvastatin, erlotinib and OSI-420 in rat serum and liver microsomes using a novel liquid chromatography-mass spectrometry method. Journal of Pharmaceutical and Biomedical Analysis. 236. 115716–115716. 2 indexed citations

10.

Grube, Markus, et al.. (2023). The influence of OATP2B1 and atorvastatin on coproporphyrin isomers in rats. Journal of Pharmacological Sciences. 153(3). 170–174. 1 indexed citations

11.

Seibert, Isabell, et al.. (2023). Influence of Slco2b1‐knockout and SLCO2B1‐humanization on coproporphyrin I and III levels in rats. British Journal of Pharmacology. 181(1). 36–53. 10 indexed citations

12.

Seibert, Isabell, et al.. (2021). Differences in transport function of the human and rat orthologue of the Organic Anion Transporting Polypeptide 2B1 (OATP2B1). Drug Metabolism and Pharmacokinetics. 41. 100418–100418. 10 indexed citations

13.

Schwabedissen, Henriette E. Meyer zu, et al.. (2020). Genetic variants of SLCO1B7 are of relevance for the transport function of OATP1B3-1B7. Pharmacological Research. 161. 105155–105155. 4 indexed citations

14.

Duthaler, Urs, et al.. (2019). OATP1B3-1B7 (LST-3TM12) Is a Drug Transporter That Affects Endoplasmic Reticulum Access and the Metabolism of Ezetimibe. Molecular Pharmacology. 96(2). 128–137. 7 indexed citations

15.

Potterat, Olivier, et al.. (2018). Hyperforin-Induced Activation of the Pregnane X Receptor Is Influenced by the Organic Anion-Transporting Polypeptide 2B1. Molecular Pharmacology. 95(3). 313–323. 21 indexed citations

16.

Schwabedissen, Henriette E. Meyer zu, et al.. (2018). Thyroid Hormones Are Transport Substrates and Transcriptional Regulators of Organic Anion Transporting Polypeptide 2B1. Molecular Pharmacology. 94(1). 700–712. 22 indexed citations

17.

Heyman, Heino, François Sénéjoux, Isabell Seibert, et al.. (2015). Identification of anti-HIV active dicaffeoylquinic- and tricaffeoylquinic acids in Helichrysum populifolium by NMR-based metabolomic guided fractionation. Fitoterapia. 103. 155–164. 60 indexed citations

18.

Louvel, Séverine, Nivan Moodley, Isabell Seibert, et al.. (2013). Identification of compounds from the plant species Alepidea amatymbica active against HIV. South African Journal of Botany. 86. 9–14. 17 indexed citations

19.

Lubbe, Andrea, Isabell Seibert, Thomas Klimkait, & Frank van der Kooy. (2012). Ethnopharmacology in overdrive: The remarkable anti-HIV activity of Artemisia annua. Journal of Ethnopharmacology. 141(3). 854–859. 80 indexed citations

20.

Albert, E. D., Isabell Seibert, Zhongyuan Yao, et al.. (1997). A NOVEL DRB1*0801 HAPLOTYPE CARRYING DRB3*0202 FOUND IN A GERMAN PEDIGREE. European Journal of Immunogenetics. 24(6). 435–437. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact